Endo International Plc (ENDP)

Trade ENDP now with
11/4/2019 4:28:47 PM Endo President And CEO Paul Campanelli To Retire; Named Chairman
11/4/2019 4:26:50 PM Endo Q3 Loss/share $0.35 Vs. Loss $0.77 Year Ago
11/4/2019 4:24:26 PM Endo International plc (ENDP) Has Raised Its 2019 EPS Estimate To 2.10 - 2.25 From 2.00 - 2.25
10/24/2019 7:54:37 AM Endo Presents Data On Use Of A Standing MRI For The Evaluation Of Cellulite At ASDS Annual Meeting
10/7/2019 6:32:22 AM Nevakar Enters Into $17.5 Mln Product Financing Deal With H.I.G. For Continued Development Of Injectable Products
9/30/2019 7:31:42 AM Endo Reports Culmination Of Litigation Regarding FDA Compounding Policy
9/6/2019 10:30:28 AM Endo Submits BLA For Collagenase Clostridium Histolyticum For Treatment Of Cellulite In The Buttocks
9/5/2019 7:07:51 AM Endo To Present New XIAFLEX Data At 2019 ASSH Annual Meeting
9/4/2019 7:31:31 AM Endo Announces Approval Of First Generic Orfadin In U.S.
9/3/2019 6:31:19 AM Endo Launches Authorized Generic Version Of Noxafil Delayed-release Tablets In The United States
8/21/2019 8:46:00 AM Perrigo Settles Hatch-Waxman Litigation Relating To Nascobal Nasal Spray Brought By Endo Pharma
8/20/2019 9:30:27 AM Endo Reorts Settlement In Principle To Resolve "Track 1" Opioid Cases